Clinical Trial Update: Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study in treatment-naive chronic hepatitis C patients sponsored by Bristol-Myers Squibb; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED